Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Teladoc Health Inc (TDOC) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Teladoc Health IncTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Teladoc Health Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Teladoc Health Inc trades at $5.79 (market cap $1.09B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Teladoc Health Inc for 39 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TDOCVIR
Market Cap
$1.09B$1.80B
Volume
4,279,2681,782,836
Sector
HealthHealth
52-Week High
$9.72$11.78
52-Week Low
$4.47$5.12
Typical Hold Time
39 Days0 Days
Enterprise Value
$1.35B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Teladoc Health Inc

Teladoc Health (TDOC) trades at $5.81, down 1.86% on the day, with a bearish technical signal and mixed quarterly earnings performance. The company maintains strong gross margins at 68.97% but continues to report net losses, with a -7.13% net income margin for 2025. Recent developments include new executive appointments and ongoing legal investigations, while analyst consensus shows 35.71% buy ratings with a $8.83 price target.

TDOC presents a turnaround opportunity with attractive valuation metrics (P/S 0.43, EV/EBITDA 6.28) and positive cash flow from operations, but faces significant execution risks from persistent losses, BetterHelp segment challenges, and legal scrutiny. The stock trades near multi-year lows, offering potential upside if management can stabilize the business and return to profitability.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TDOC
12% Buy88% Sell
Avg holding period · 39 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →